Capital Radiation Therapy is categorized under Doctors in Olympia, WA .
Capital Radiation Therapy was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mike Henslee, Office Manager at the company’s single location by writing to 3920 Capital Mall Drive Sw, Olympia, Washington WA 98502 or by phoning (360) 596-4872. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Capital Radiation Therapy |
| Contact Person: | Mike Henslee, Office Manager |
| Address: | 3920 Capital Mall Drive Sw, Olympia, Washington 98502 |
| Phone Number: | (360) 596-4872 |
| Website Address: | capitalmedical.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Capital Radiation Therapy was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mike Henslee, Office Manager for inquiries that concern Capital Radiation Therapy by calling the company number (360) 596-4872, as your correspondence is most welcome. Additionally, the physical location of the single location of Capital Radiation Therapy can be found at the coordinates 47.04181,-122.95227 as well as the street address 3920 Capital Mall Drive Sw in Olympia, Washington 98502.
For its online presence, you may visit Capital Radiation Therapy’s website at capitalmedical.com and engage with its social media outlets through on Twitter and on Facebook.